Orange Book product · Brand (NDA)
VYZULTA
LATANOPROSTENE BUNOD
Brand (NDA)NDA 207795TE ABRX BAUSCH AND LOMB
At a glance
Nov 02, 2017
Approved
Brand (NDA)
Application
AB
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 02, 2017
8 yr 9 mo ago
Today
Patent 8058467 expires
Listed drug substance patent expiration.
Feb 21, 2029
in 2 yr 9 mo
Pharmaceutical detail
Active ingredient
LATANOPROSTENE BUNOD
Strength
0.024%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AB
Application
NDA 207795
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8058467 | Feb 21, 2029 | in 2 yr 9 mo | SubstanceU-2144 |
